AmerisourceBergen Packaging Group Welcomes Rosalyn Wesley, Vice President, Human Resources

Rosalyn Wesley has been named Vice President of Human Resources for AmerisourceBergen Packaging Group (ABPG). In her new role, Ms. Wesley will oversee human resources responsibilities for ABPG subsidiary companies: Anderson Packaging (Rockford, IL), American Health Packaging (Columbus, OH), and Brecon Pharmaceuticals (Hay-on-Wye, Wales, UK).

Hp 19025 R Wesley Aug09 Comp

This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.

The three operations employ a highly-trained, global workforce of more than 1,500 pharmaceutical packaging associates.

Ms. Wesley brings extensive industry experience to AmerisourceBergen Packaging Group, most recently as Corporate Director of Human Resources at Fortune Brands Inc. Prior to her employment at Fortune Brands, she held human resource management positions at Motorola Inc. and Kraft Foods Corp. She is a graduate of Knoxville College in Tennessee.

"We are thrilled to have Rosalyn join AmerisourceBergen Packaging Group,” explains Ed Hancock, president of AmerisourceBergen Packaging Group. “Rosalyn brings strength and leadership in many areas and we anticipate a very positive impact across the organization.”
Pharmaceutical Innovations Report
Discover the latest breakthrough packaging technologies shaping the pharmaceutical sector. This report dives into cutting-edge innovations, from smart containers that enhance patient safety to eco-friendly materials poised to transform the industry’s sustainability practices. All from PACK EXPO. Learn how forward-thinking strategies are driving efficiency and redefining what’s possible in pharma packaging.
Learn More
Pharmaceutical Innovations Report
FDA warning letters surge - is your team prepared?
New guide reveals expert strategies to prevent regulatory issues and respond effectively to FDA enforcement actions in pharmaceutical and medical device manufacturing.
Read More
FDA warning letters surge - is your team prepared?